Anthracyclines such as doxorubicin are widely used chemotherapy drugs. A common side
effect of anthracycline therapy is cardiotoxicity, which can compromise heart function and …

Background Cardiotoxicity is one of the most common adverse events of the chemotherapy.
Physical exercise was shown to be cardioprotective. We aim to estimate the efficacy and …

Simple Summary In addition to cancer-related factors, anti-cancer chemotherapy treatment
can drive life-threatening body wasting in a syndrome known as cachexia. Emerging …

Doxorubicin (DOX) is an extensively used chemotherapeutic agent that can cause severe
and frequent cardiotoxicity, which limits its clinical application. Although there have been …

A cachexia diagnosis is associated with a doubling in hospital stay and increased
healthcare cost for cancer patients and most cachectic patients do not survive treatment …

The anthracycline antibiotic doxorubicin (DOX) is an effective anticancer agent, but its
clinical use is limited by dose‐dependent cardiotoxicity. Scutellarin (SCU), a natural …

Doxorubicin (DOX) is a highly effective antineoplastic agent used in cancer treatment.
Unfortunately, clinical use of DOX is limited due to the development of dose-dependent …

Significance: Cancer is frequently associated with the early appearance of cachexia, a
multifactorial wasting syndrome. If not present at diagnosis, cachexia develops either as a …

Doxorubicin (DOX) is a highly effective chemotherapy agent prescribed for cancer treatment.
However, the clinical use of DOX is limited due to off-target toxicity in healthy tissues. In this …

Doxorubicin (DOX) is a highly effective antitumor agent used for the treatment of a wide
range of cancers. Unfortunately, DOX treatment results in cytotoxic side effects due to its …